Table 3. Few Sub-Saharan Studies Documented the Management of Localized Prostate Cancer.
Study | Localized CaP (%) | Gleason | Available treatment modality | Outcome |
---|---|---|---|---|
Niang et al [24] | < 27% | Radical prostatectomy, bilateral orchiectomy, hormonotherapy | ||
Tengue et al [14] | 6.40% | Radical prostatectomy (6.4%) hormonotherapy (93.1%) | 15.1% mortality | |
Anumobi et al [15] | 9 | |||
Kyei et al [10] | Localized | 6 | Radical prostatectomy/radiotherapy/hormonotherapy | Anastomotic urethral stricture, bladder neck stenosis |
Kabore et al [16] | 13.10% | Hormonotherapy, radical prostatectomy | ||
Wasike et al [17] | 12.50% | 8 | 7.7% mortality | |
Kabore et al [18] | < 26% | ≥ 7 | ||
Badmus et al [22] | 5.80% | Hormonotherapy | ||
Gueye et al [19] | 43.80% | |||
Obiorah et al [20] | 8 | |||
Babacar et al [21] | Localized | 6 | Radical prostatectomy | Incontinence, erectile dysfunction |
Ikuerowo et al [25] | 26% | > 7 | ||
Yamoah et al [26] | 34.60% | ≤ 6 | EBRT, brachytherapy, hormonotherapy |
CaP: prostate cancer; EBRT: external beam radiation therapy.